On November 12, 2026, Kieu Huu, Chairman of Vidipha Central Pharmaceutical JSC (HoSE: VDP), submitted a letter asking to leave both his chairman post and his board seat. Five others filed the same day: board members Hoang The Bac, Tran Van Dat and Pham Tuan Kiet, plus Doan Thi Ngoc Boi, Head of the Supervisory Board, and Nguyen Quang Toan, a Supervisory Board member. According to Vidipha's notice to HoSE on November 13, all six cited personal reasons and a lack of time.FireAnt
The business itself kept moving. In Q3 2026, net revenue topped VND 230 billion, up 16% year on year, and net profit reached VND 15.6 billion, up 30%.CafeF What deserves attention is something else: who will fill the vacant seats, and which shareholders hold enough votes to decide.
Letters received, nobody dismissed yet
The key line in the notice is the last one: all six asked to be relieved from the date the general meeting of shareholders (AGM) approves. So far Vidipha has only received the letters and has not relieved anyone. All six keep their seats until shareholders vote.
To see who will hold the votes at that meeting, we need to go back more than a year.

From DSC to the 100:45 rights offering
On October 8, 2025, DSC Securities completed the purchase of 3.3 million VDP shares, lifting its stake from 4.92% to 19.77% of the charter capital at the time and overtaking Vietnam Pharmaceutical Corporation (Vinapharm) as the largest shareholder.Mekong Asean On January 8, 2026, an extraordinary AGM considered resignation letters from two board members, Kieu Thi Minh Hong and Nguyen Tran Hieu, and elected replacements. The two candidates were Nguyen Duc Anh, Chairman of DSC Securities, and Bach Quoc Vinh, DSC's CEO, nominated by a group of shareholders that included DSC and Trinh Quang Nghia. After the meeting, Vinh became Vice Chairman of Vidipha's board.Vietnam Finance
The process then mirrors what is coming now: resignation letters taken to a meeting, with new directors elected at the same session. Only the scale is much larger this time.
At the same January meeting, the board proposed offering nearly 9.94 million shares to existing shareholders. As implemented, the ratio was 100:45 at VND 10,000 per share, with the record date on July 24, 2026 and subscription and payment from August 5 to 26. The proceeds are earmarked for a Cephalosporin powder-for-injection line meeting EU-GMP standards, with total investment of about VND 127.8 billion.Báo Pháp luật
August: old leadership group sells, three individuals become major shareholders
Just as the offering opened, shares held by the long-serving leadership group changed hands. According to CafeF on November 14:CafeF
- Kieu Huu sold his entire holding of more than 1.65 million shares, or 7.48% of capital.
- His daughter, Kieu Thuy Mai, sold her entire holding of nearly 1.38 million shares, or 6.23%.
- Tran Van Dat sold 899,320 shares; his wife, Nguyen Thi Anh Thuy, sold more than 1.02 million.
- Dinh Thi Hoang Oanh, wife of Pham Tuan Kiet, sold more than 2.5 million shares, about 11.5% of capital, completed on August 20.
Together, the group sold nearly 7.5 million shares, about 34% of the charter capital at the time, valued at nearly VND 277 billion by the outlet's estimate.FireAnt These shareholders also transferred their subscription rights and did not take part in the offering.CafeF

The scope matters. The sellers are Kieu Huu, Tran Van Dat and relatives of three board members. Hoang The Bac, Doan Thi Ngoc Boi and Nguyen Quang Toan do not appear on the list.
Over the same period, three individuals became major shareholders in turn. Le Quang Hai bought more than 4.95 million shares and at one point held 22.5% of the old capital. Nguyen Quoc Hung paid nearly VND 101.5 billion for more than 2.5 million shares in a negotiated deal on August 12. Nguyen Thi Yen also appeared on the new major-shareholder list.Báo Pháp luật No disclosure says these three bought the old leadership group's shares or the transferred rights, so this post records only two events running in parallel.
Capital above VND 320 billion, a redrawn shareholder map
The offering ended in late September: shareholders registered and paid for 9,758,070 shares, and the leftover 174,915 shares were sold by the board at VND 10,000 to Hai and Hung. In total, 9,932,985 shares were distributed, raising about VND 99.33 billion and lifting charter capital to VND 320.164 billion, or 32,016,377 shares.Vietnam Finance
On the new capital, Hai holds 15.74%, Vinapharm 14.29%, Hung nearly 13.8% and Yen 11.96%.CafeF Including a related person, Nguyen Quoc Anh, Hung's stake is 15.047%.

DSC remains among the major shareholders, but its stake needs careful reading. CafeF reports 19.84%, while the roughly 4.37 million shares Vietnam Finance attributes to DSC equal only about 13.6% of 32,016,377 shares. The two figures match only if DSC bought more in the offering. This post therefore draws no bar for DSC and does not add its stake to anyone else's.
Who is left on the board
Kieu Huu and Hoang The Bac have sat on Vidipha's board since April 7, 2012. Pham Tuan Kiet and Tran Van Dat joined on April 24, 2021. On the Supervisory Board, Toan has served since June 1, 2020, and Boi has been head since April 24, 2021.
If all six letters are approved, the board keeps three members: Bach Quoc Vinh, Ha Lan Anh and Nguyen Duc Anh, all elected at the January 8, 2026 meeting. The Supervisory Board keeps only Nguyen Thi Thuy.CafeF Bac's letter covers only his board seat. He is currently Deputy General Director of Vidipha, and that executive role is not in the letter.
How the company is running during the handover
For the first nine months, Vidipha posted net revenue of about VND 658 billion, up 4%, and pre-tax profit of VND 58.9 billion, up 5.5%, or about 65.4% of the full-year plan of VND 90 billion.CafeF Q3 profit grew faster than revenue, so operations did not deteriorate in the quarter when ownership shifted.

Next milestone: the AGM
The resignations take effect only when the AGM approves them, so Vidipha must convene a meeting. No record date or meeting date has been announced. Going by the January 2026 precedent, replacements will be elected at the same session, and the meeting notice will carry a record date: only holders on that date can vote.
Under the 2020 Enterprise Law, a shareholder or group holding at least 5% of common shares may nominate candidates to the board and Supervisory Board. At Vidipha, Hai, Hung, Yen, Vinapharm and DSC all clear that bar, and each can nominate alone.
The chairman is elected by the new board itself, so the first document showing Vidipha's direction will be the meeting materials: the candidate lists for the board and Supervisory Board, with the nominating shareholder for each name. If candidates come from Hai, Hung or Yen, the three new shareholders will have seats on the board for the first time. If they come mainly from DSC or Vinapharm, the new board will lean toward shareholders present before August. Both scenarios are measured by the same yardstick: the nominations in the meeting materials, then the vote.
For anyone holding VDP, including those who paid VND 10,000 per share in August, this is the first time since the change in shareholders that their vote directly helps choose the people who run and oversee the company.

